Patent · US Active

Baclofen formulations and methods for making same

US9597304B2 · kind B2 · utility

2Cited by
1References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 6, 2015
Grant dateMar 21, 2017
Priority date
Expiry dateNov 6, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/0019
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for preparing sterilized baclofen solutions include adjusting the pH to below a desired pH, and steam sterilizing the solution with adjusted pH, which results in the solution having the desired pH. Such solutions may also have low concentrations of 4-CPP. Injectable baclofen solutions having greater than 2 mg/mL baclofen include between 5 mM and 25 mM of a phosphate or sulfate species. The solution has an ionic strength equivalent of about 1.5 M NaCl. The present application also provides baclofen formulations for use in treating spasticity, brain injury, cerebral palsy, spinal cord injury, cervical injury, multiple sclerosis, thoracic injury, or withdrawal symptoms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.